2 days Ago Eli Lilly ( NYSE: LLY ) is reportedly seeking to oppose a lawsuit filed by compounding pharmacies over the FDA's determination that weight-loss and diabetes drugs such as Lilly's ( NYSE: LLY ) tirzepatide are no longer in short supply. Lilly ( LLY ) filed a motion.
